CytomX Therapeutics, Inc. (CTMX) shares outstanding

Shares outstanding · fiscal 2025
137.94M

CytomX Therapeutics, Inc. (CTMX) had 137.94M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 62.8% higher than the 84.75M of fiscal 2024. Figures as of 18 Nov 2026, 11:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
137.94M
Change on fiscal 2024
+62.8%
Growth, 5 years
+24.5% a year
Highest on record
137.94Mfiscal 2025
Lowest on record
45.34Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

CytomX Therapeutics, Inc. shares outstanding, in more detail

The market data feed counts 218.00M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 24.5% a year. Across the 7 fiscal years on record (2019–2025), the highest was 137.94M in fiscal 2025 and the lowest 45.34M in fiscal 2019.

History · 7 fiscal years

Shares outstanding by fiscal year

CytomX Therapeutics, Inc. shares outstanding, year by year

CytomX Therapeutics, Inc. (CTMX) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025137.94M 62.8% up
202484.75M 14.8% up
202373.81M 12.3% up
202265.74M 2.5% up
202164.15M 39.0% up
202046.15M 1.8% up
201945.34M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on CTMX

CytomX Therapeutics, Inc., figure by figure

CytomX Therapeutics, Inc. (CTMX) overview: price, valuation and scorecard

CytomX Therapeutics, Inc. shares outstanding: questions and answers

How many shares does CytomX Therapeutics, Inc. have?

CytomX Therapeutics, Inc. (CTMX) had 137.94M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 62.8% higher than the 84.75M of fiscal 2024. The market data feed counts 218.00M shares outstanding today.

What is the growth rate of CytomX Therapeutics, Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 24.5% a year.

What are the highest and lowest diluted share count figures on record for CytomX Therapeutics, Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was 137.94M in fiscal 2025 and the lowest 45.34M in fiscal 2019.

How is CytomX Therapeutics, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For CytomX Therapeutics, Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “CytomX Therapeutics, Inc. (CTMX) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/CTMX/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.